The Role Of PD-1/PD-L1 Axis In Treg Development And Function: Implications For Cancer Immunotherapy
During the past decade, immunotherapy targeting immune checkpoints has become an important component of the treatment paradigm for numerous malignancies, especially PD-1/PD-L1 blockade which was demonstrated to rejuvenate disabled T cells in cancer patients to achieve long-term remissions. However,...
Saved in:
Published in | OncoTargets and therapy Vol. 12; pp. 8437 - 8445 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Macclesfield
Taylor & Francis Ltd
01.01.2019
Dove |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!